News
UCD team uses novel polymer-based system to deliver corrective genes, an approach that appears to be better tolerated by ...
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
A man who was the first person in the UK to receive a groundbreaking gene-editing therapy on the NHS, said he felt " ...
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo ...
We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with genetic diseases?
5d
Study Finds on MSNNew Gene Therapy Repairs Deafness Gene, Restores Hearing In Landmark Clinical TrialA new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...
Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...
Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...
12d
Zacks.com on MSNCRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.
The FDA has granted rare pediatric disease designation to PBGENE-DMD, an experimental gene-editing therapy for Duchenne ...
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results